| 名稱 | CCDC6-RET WT/BaF3 |
| 型號(hào) | CBP73214 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CCDC6-RET WT/BaF3,母細(xì)胞：BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 上海細(xì)胞中心人員需了解的專業(yè)“術(shù)語(yǔ)”
- 【產(chǎn)品推介】IL12細(xì)胞篩選模型
- 上海細(xì)胞庫(kù)——南京科佰生物
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 長(zhǎng)期研究使用的腦癌細(xì)胞系或面臨“身份危機(jī)”
- IL-11藥物細(xì)胞模型介紹
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 科佰Bcr-AbL激酶細(xì)胞模型助力客戶發(fā)表高分文獻(xiàn)（IF 15.1）
- 一箭雙雕——IL-4R靶點(diǎn)和IL-4/IL-13雙重阻斷藥篩細(xì)胞模型
- IL9細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73214CCDC6-RET WT/BaF3
- 詳細(xì)內(nèi)容
| CBP73214 | |
| I. Introduction | |
Cell Line Name： | CCDC6-RET WT/BaF3 |
Host Cell: | BA/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
| III. Representative Data | |
1. WB of CCDC6-RET WT/BaF3WT
| |
2. Sanger of CCDC6-RET WT/BaF3
Figure 2. Breakpoint of CCDC6-RET WT/BaF3 | |
2. Anti-proliferation assay | |
Figure 3. CTG assay of for CCDC6-RET WT/BaF3 Stable Cell Line,the Gi50 was 137.3nM. | |
會(huì)員_a.png)